NVNO Stock Summary and Trading Ideas (Envveno Medical | NASDAQ:NVNO)

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

What symbol and exchange does Envveno Medical shares trade?

Envveno Medical trades on the NASDAQ stock market under the symbol NVNO.

What is Envveno Medical stock price doing today?

As of March 20, 2026, NVNO stock price declined to $11.56 with 16,150 million shares trading.

What is Envveno Medical's Beta?

NVNO has a beta of 2.00, meaning it tends to be more sensitive to market movements. NVNO has a correlation of 0.03 to the broad based SPY ETF.

How much is Envveno Medical worth?

NVNO has a market cap of $7.57 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Envveno Medical traded in the last 3 year period?

In the last 3 years, NVNO traded as high as $243.95 and as low as $8.67.

What are the top ETFs holding Envveno Medical?

The top ETF exchange traded funds that NVNO belongs to (by Net Assets): VXF, IWC.

Is Envveno Medical (NVNO) a good investment?

NVNO has underperformed the market in the last year with a return of -88.6%, while SPY returned +16.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NVNO shares. However, NVNO has outperformed the market in the last 3 month and 2 week periods, returning +3.2% and +0.9%, while SPY returned -4.4% and -3.3%, respectively. This indicates NVNO has been having a stronger performance recently.

What are the support and resistance levels for Envveno Medical (NVNO)?

NVNO support price is $11.12 and resistance is $13.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVNO shares will trade within this expected range on the day.